The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections

Background/Aim. The Professional System of Continuous Glucose Monitoring, the iPro®2 CGM System (Medtronic) is designed to be worn together with a glucose sensor with an electrode inserted into the subcutaneous tissue, up to 7 days, without insight into the current level of glycemia. After reading d...

Full description

Bibliographic Details
Main Authors: Bukara-Radujković Gordana, Miljković Vesna, Lakić Siniša
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2018-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501800106B.pdf
_version_ 1811195674826375168
author Bukara-Radujković Gordana
Miljković Vesna
Lakić Siniša
author_facet Bukara-Radujković Gordana
Miljković Vesna
Lakić Siniša
author_sort Bukara-Radujković Gordana
collection DOAJ
description Background/Aim. The Professional System of Continuous Glucose Monitoring, the iPro®2 CGM System (Medtronic) is designed to be worn together with a glucose sensor with an electrode inserted into the subcutaneous tissue, up to 7 days, without insight into the current level of glycemia. After reading data from the iPro®2 device, a realistic picture of the glycemia movement during the period of wearing the device is obtained. The aim of the study was to examine whether objective measurement information collected through the use of professional continuous glucose monitoring (CGM) contribute to improved metabolic control in children with type 1 diabetes mellitus who are on the multiple daily insulin injections (MDI). Methods. The study was conducted on 24 patients (14 girls) aged 5 to 18 years, with an average age 12 ± 3.3 years, in the period from June to December 2016 in the Clinic of Pediatrics, University Clinical Center of the Republic of Srpska in Banja Luka. Glycated hemoglobin (HbA1c) was measured in the laboratory at the start of the trial and 3 months afterwards in order to determine the effect of wearing professional iPro®2 on metabolic control, and then three months later, to test for the long-lasting effects in the absence of iPro®2 monitoring. Results. The initial HbA1c was 7.78 ± 1.17% (min: 5.50%; max: 10.00%). After 3 months, HbA1c showed a statistically significant decrease to 7.34 ± 0.84% (min: 5.60%, max: 8.90%). At the six-month follow-up visit, without implementing professional CGM in the meantime, a significant increase in HbA1c was reached, with the average value of 7.68% ± 0.83% (min: 5.50%, max: 9.10%). Conclusion. This study shows that carrying a professional CGM for 7 days per month, 3 months continuously is associated with certain improvement of metabolic control in children with diabetes who are on MDI without increasing risks of hypoglicemia.
first_indexed 2024-04-12T00:47:00Z
format Article
id doaj.art-60884b44a49545a5bc7fa3b11531aa2c
institution Directory Open Access Journal
issn 0042-8450
2406-0720
language English
last_indexed 2024-04-12T00:47:00Z
publishDate 2018-01-01
publisher Military Health Department, Ministry of Defance, Serbia
record_format Article
series Vojnosanitetski Pregled
spelling doaj.art-60884b44a49545a5bc7fa3b11531aa2c2022-12-22T03:54:51ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502406-07202018-01-0175121209121510.2298/VSP170908106B0042-84501800106BThe effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injectionsBukara-Radujković Gordana0Miljković Vesna1Lakić Siniša2nemanemanemaBackground/Aim. The Professional System of Continuous Glucose Monitoring, the iPro®2 CGM System (Medtronic) is designed to be worn together with a glucose sensor with an electrode inserted into the subcutaneous tissue, up to 7 days, without insight into the current level of glycemia. After reading data from the iPro®2 device, a realistic picture of the glycemia movement during the period of wearing the device is obtained. The aim of the study was to examine whether objective measurement information collected through the use of professional continuous glucose monitoring (CGM) contribute to improved metabolic control in children with type 1 diabetes mellitus who are on the multiple daily insulin injections (MDI). Methods. The study was conducted on 24 patients (14 girls) aged 5 to 18 years, with an average age 12 ± 3.3 years, in the period from June to December 2016 in the Clinic of Pediatrics, University Clinical Center of the Republic of Srpska in Banja Luka. Glycated hemoglobin (HbA1c) was measured in the laboratory at the start of the trial and 3 months afterwards in order to determine the effect of wearing professional iPro®2 on metabolic control, and then three months later, to test for the long-lasting effects in the absence of iPro®2 monitoring. Results. The initial HbA1c was 7.78 ± 1.17% (min: 5.50%; max: 10.00%). After 3 months, HbA1c showed a statistically significant decrease to 7.34 ± 0.84% (min: 5.60%, max: 8.90%). At the six-month follow-up visit, without implementing professional CGM in the meantime, a significant increase in HbA1c was reached, with the average value of 7.68% ± 0.83% (min: 5.50%, max: 9.10%). Conclusion. This study shows that carrying a professional CGM for 7 days per month, 3 months continuously is associated with certain improvement of metabolic control in children with diabetes who are on MDI without increasing risks of hypoglicemia.http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501800106B.pdfdiabetes mellitus, type 1childbosnia and herzegovinadrug monitoringinsulinblood glucose self monitoring
spellingShingle Bukara-Radujković Gordana
Miljković Vesna
Lakić Siniša
The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
Vojnosanitetski Pregled
diabetes mellitus, type 1
child
bosnia and herzegovina
drug monitoring
insulin
blood glucose self monitoring
title The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
title_full The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
title_fullStr The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
title_full_unstemmed The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
title_short The effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
title_sort effects of three month long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections
topic diabetes mellitus, type 1
child
bosnia and herzegovina
drug monitoring
insulin
blood glucose self monitoring
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501800106B.pdf
work_keys_str_mv AT bukararadujkovicgordana theeffectsofthreemonthlongcontinuousglucosemonitoringinchildrenwithtype1diabetesonmultipledailyinsulininjections
AT miljkovicvesna theeffectsofthreemonthlongcontinuousglucosemonitoringinchildrenwithtype1diabetesonmultipledailyinsulininjections
AT lakicsinisa theeffectsofthreemonthlongcontinuousglucosemonitoringinchildrenwithtype1diabetesonmultipledailyinsulininjections
AT bukararadujkovicgordana effectsofthreemonthlongcontinuousglucosemonitoringinchildrenwithtype1diabetesonmultipledailyinsulininjections
AT miljkovicvesna effectsofthreemonthlongcontinuousglucosemonitoringinchildrenwithtype1diabetesonmultipledailyinsulininjections
AT lakicsinisa effectsofthreemonthlongcontinuousglucosemonitoringinchildrenwithtype1diabetesonmultipledailyinsulininjections